Congenital Diaphragmatic Hernia Panel
Use
This test is intended for individuals with relevant features who have a clinical or suspected diagnosis of congenital diaphragmatic hernia. It is also suitable for individuals with isolated or complex CDH who require a genetic diagnosis for management and counseling. Patients with a family history of congenital diaphragmatic hernia or those with abnormal prenatal ultrasound findings suggestive of this condition can also benefit from this genetic testing.
Special Instructions
Not provided.
Limitations
The tests were developed and validated by PreventionGenetics LLC following CAP and CLIA regulations. However, these tests have not been approved or cleared by the US Food and Drug Administration.
Methodology
NGS (Targeted)
Biomarkers
No genes
Gene
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
